Table 4.
Medications used in acute management of hyperammonemia and their dosages
Medications | Mechanism of action | Dosage | Route | Adverse reaction* |
---|---|---|---|---|
Sodium benzoatea | Conjugation with glycine to form hippuric acid | Weight ≤20 kg: 250 mg/kg as loading dose over 90 minutes followed by 250–500 mg/kg/day Weight >20 kg: 5.5 g/m2 as loading dose over 90 minutes followed by 5.5 g/m2/dayb |
IV | Cardiovascular: hypotension Dermatologic: injection site reaction Electrolytes imbalance: hyperglycemia, hypokalemia, hypernatremia Gastrointestinal: vomiting, diarrhea CNS: altered mental status, seizure, cerebral edema Other: fever |
Sodium phenylacetatea | Conjugation with glutamine to form phenylacetylglutamine | Same as for Sodium benzoate | IV | Same as for Sodium benzoate |
AMMONUL®c | Contains both sodium benzoate and sodium phenylacetate | Same as for Sodium benzoate | IV (AMMONUL® could be given through peripheral line on limited basis) | Same as for Sodium benzoate |
L-Arginine | As an intermediate metabolite in the urea cycle. It can improve the flow through the urea cycle and thereby improves ammonia removal | 250–400 mg/kg/day as loading dose over 90 minutes followed by 250–400 mg/kg/day | IV | Hyperchloremic metabolic alkalosis, hypokalemia, elevated BUN and creatinine levels, flushing, nausea, vomiting, abdominal cramps, bloating, numbness, headache |
Carbaglu® (carglumic acid)d | Replace N-acetylglutamate as an activator of mitochondrial carbamoyl phosphate synthetase, the first enzyme of the urea cycle | 100 mg/kg bolus per NG tube, then 25–62.5 mg/kg every 6 hours | NG | Abdominal pain, diarrhea, vomiting, anemia, otitis media, tonsillitis, nasopharyngitis, fever, headache |
Notes:
It should be given through central line, however, could be given peripherally on limited basis.
If on hemodialysis/hemodiafiltration, maintenance doses should be increased to 350 mg/kg/day (or proportional increase for body surface-based dose calculation).
It is supplied as a vial of 50 mL or 5,000 mg constituted of concentrated, aqueous 10% sodium benzoate and 10% sodium phenylacetate solution. Thus, each mL provides 100 mg of sodium benzoate and 100 mg of sodium phenylacetate in water. According to the prescribing information, AMMONUL must be diluted with sterile dextrose injection, 10% at ≥25 mL/kg before administration.
It is supplied as 200 mg tablet; 5 or 60 tablets in a polypropylene bottle with polyethylene cap and desiccant unit.
Generally all the drugs are well tolerated and adverse reactions are only relevant if dosages are very high.
Abbreviations: BUN, blood urea nitrogen; IV, intravenous; NG, nasogastric; CNS, central nervous system.